Greater Baltimore Medical Center Land Corporation

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Panomics Relationships in the Epidemiology of Cancer Through In Silico Expression (PRECISE)

Withdrawn

Conditions: Patients With a Suspected or Confirmed Diagnosis of Cancer
Cancer
Patients With Clinical and Environmental Risk Factors for Cancer

Interventions: Other: Patients with CA or suspected risk of CA or a family Hx

First Posted Date: 2017-10-09

Last Posted Date: 2020-07-22

Lead Sponsor: Greater Baltimore Medical Center

Registration Number: NCT03304990

Locations: 🇺🇸
Greater Baltimore Medical Center, Baltimore, Maryland, United States

Treatment Plan for an Individual Patient With Recurrent Uterine Papillary Serous Carcinoma (UPSC) With PIK3CA Gene Mutation

Phase 2

Completed

Conditions: Uterine Cancer

Interventions: Drug: Letrozole
Drug: Everolimus

First Posted Date: 2017-09-18

Last Posted Date: 2020-02-05

Lead Sponsor: Greater Baltimore Medical Center

Target Recruit Count: 1

Registration Number: NCT03285802

Locations: 🇺🇸
Greater Baltimore Medical Center, Baltimore, Maryland, United States

Prev
1
Next

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy